BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34157945)

  • 1. Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.
    Zhang F; Guo R; Cui W; Wang L; Xiao J; Shang J; Zhao Z
    Ren Fail; 2021 Dec; 43(1):980-992. PubMed ID: 34157945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
    Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
    Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-mass spectrometry untargeted metabolomics reveals increased levels of tryptophan indole metabolites in urine of metabolic syndrome patients.
    Esperanza MG; Wrobel K; Ojeda AG; Garay-Sevilla ME; Escobosa ARC; Barrientos EY; Wrobel K
    Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):379-387. PubMed ID: 33295818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
    Qian F; Zhao L; Zhang D; Yu M; Zhou W; Jin J
    FEBS Open Bio; 2023 Oct; 13(10):1844-1858. PubMed ID: 37525631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
    Tian C; Qiu M; Lv H; Yue F; Zhou F
    J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls.
    Tao S; Zheng W; Liu Y; Li L; Li L; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Ma L; Fu P
    RSC Adv; 2019 Jun; 9(33):18713-18719. PubMed ID: 35516902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated 16S rRNA Sequencing and Untargeted Metabolomics Analysis to Reveal the Protective Mechanisms of
    Zhang H; Li H; Pan B; Zhang S; Su X; Sun W; Zhang T; Zhang Z; Lv S; Cui H
    Curr Drug Metab; 2023; 24(4):270-282. PubMed ID: 37038712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of circulating metabolic signature of erythrodermic psoriasis based on LC-MS metabolomics.
    Guo L; Wu C; Song B; Jin HZ
    Exp Dermatol; 2024 May; 33(5):e15103. PubMed ID: 38794829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
    Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
    Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
    J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry.
    Nilavan E; Sundar S; Shenbagamoorthy M; Narayanan H; Nandagopal B; Srinivasan R
    Diabetes Metab Syndr; 2020; 14(6):2073-2078. PubMed ID: 33125920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
    Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
    J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
    Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
    Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing the Hypoglycemic Effects and Mechanism of GABA-Rich Germinated Adzuki Beans on T2DM Mice by Untargeted Serum Metabolomics.
    Jiang X; Xu Q; Zhang A; Liu Y; Li Z; Tang H; Cao D; Zhang D
    Front Nutr; 2021; 8():791191. PubMed ID: 34970582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.